Shanghai Fudan Forward S&T Co

Shanghai Fudan Forward S&T Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Shanghai Fudan Forward S&T Co (600624.SS) as of Nov 5, 2026 is -66.18. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -198.30 — a change of -66.63% (higher).

EV/FCF

-66.18

YoY

-66.63%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Shanghai Fudan Forward S&T Co is 2025 -66.18 . EV/FCF (Enterprise Value to Free Cash Flow) of Shanghai Fudan Forward S&T Co was 2024 -198.30 . It decreases by -66.63% higher compared to the previous year.

The Shanghai Fudan Forward S&T Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
32.69 CNY
Jan 1, 2019
667.12 CNY
Jan 1, 2020
92.96 CNY
Jan 1, 2021
201.26 CNY
Jan 1, 2022
520.08 CNY
Jan 1, 2023
-7,951.98 CNY
Jan 1, 2024
-198.30 CNY
Jan 1, 2025
-66.18 CNY
The Shanghai Fudan Forward S&T Co EV/FCF history
YEAREV/FCFYoY
-66.18-66.63%
-198.30-97.51%
-7,951.98-1,629.00%
520.08+158.41%
201.26+116.49%
92.96-86.07%
667.12+1,940.83%
32.69-36.27%
51.29-201.30%
-50.64-74.69%
-200.07+416.16%
-38.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Fudan Forward S&T Co Stock analysis

What does Shanghai Fudan Forward S&T Co do? Shanghai Fudan Forward S&T Co., Ltd. generates revenue through the research, development, production, and sale of pharmaceutical products, including digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory drugs, and immune function medications. The company also provides financial insurance software products. Its domestic and overseas markets serve as key sales channels for these pharmaceuticals and software solutions. The firm's product portfolio targets healthcare providers, hospitals, and pharmacies within the pharmaceutical sector. The company's pharmaceutical segment focuses on specialized drug categories such as digestive system and nervous system treatments, alongside antineoplastic and circulatory drugs. Financial insurance software products complement its core pharmaceutical business, offering additional revenue streams. Domestic markets account for a significant portion of sales, while overseas markets expand its global reach. Shanghai Fudan Forward S&T Co., Ltd. leverages its 1,426 full-time employees to support both pharmaceutical and software operations. The firm's product offerings cater to healthcare institutions requiring specialized medications and digital solutions for insurance management. This dual focus allows the company to serve multiple segments within the healthcare and financial technology industries. Shanghai Fudan Forward S&T Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Fudan Forward S&T Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Shanghai Fudan Forward S&T Co is -66.18 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Shanghai Fudan Forward S&T Co changed from -198.30 to -66.18, representing a -66.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Shanghai Fudan Forward S&T Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Shanghai Fudan Forward S&T Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Shanghai Fudan Forward S&T Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Shanghai Fudan Forward S&T Co